Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy

被引：0
|
作者：
Marie Piroth
Thomas Goronflot
Romain Samaran
Emilie Varey
Alexandra Poinas
Amir Khammari
Brigitte Dreno
机构：
[1] Nantes Université,CHU Nantes Service de Dermatologie, Hôtel
[2] Nantes Université,Dieu, Nantes
[3] Hôpital du Mans,CHU Nantes, Pôle Hospitalo
[4] Nantes Université,Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413
[5] Nantes Université,Service de Dermatologie
来源：
European Journal of Dermatology | 2023年 / 33卷
关键词：
BRAF inhibitor; MEK inhibitor; melanoma; oncology; panniculitis; targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 136
页数：10
相关论文
共 50 条
  • [1] Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy
    Piroth, Marie
    Goronflot, Thomas
    Samaran, Romain
    Varey, Emilie
    Poinas, Alexandra
    Khammari, Amir
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (02) : 126 - 136
  • [2] Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practice
    Silva, Ines P.
    Long, Georgina V.
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (06) : 484 - 492
  • [3] Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm
    Khattak, Muhammad
    Fisher, Rosalie
    Turajlic, Samra
    Larkin, James
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (02) : 105 - 118
  • [4] Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    Hersey, Peter
    ONCOIMMUNOLOGY, 2012, 1 (06) : 997 - 999
  • [5] Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
    Levati, Lauretta
    Tabolacci, Claudio
    Facchiano, Antonio
    Facchiano, Francesco
    Alvino, Ester
    Cappellini, Gian Carlo Antonini
    Scala, Enrico
    Bonmassar, Laura
    Caporali, Simona
    Lacal, Pedro Miguel
    Bresin, Antonella
    De Galitiis, Federica
    Russo, Giandomenico
    D'Atri, Stefania
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [6] Targeted therapy for advanced cutaneous melanoma
    Indini, Alice
    Roila, Fausto
    Gueli, Rossana
    Grossi, Francesco
    Mandala, Mario
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (03): : 197 - 207
  • [7] Combination targeted and immune therapy in the treatment of advanced melanoma: a valid treatment option for patients?
    Bari, Shahla
    Muzaffar, Jameel
    Eroglu, Zeynep
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [8] Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma
    Di Guardo, Lorenza
    Randon, Giovanni
    Corti, Francesca
    Vallacchi, Viviana
    Raimondi, Alessandra
    Fuca, Giovanni
    Bini, Marta
    Maurichi, Andrea
    Patuzzo, Roberto
    Gallino, Gianfrancesco
    Mattavelli, Ilaria
    Ruggeri, Roberta
    Angi, Martina
    Cossa, Mara
    Valeri, Barbara
    Cimminiello, Carolina
    Santinami, Mario
    Rivoltini, Licia
    de Braud, Filippo
    Rodolfo, Monica
    Del Vecchio, Michele
    ONCOLOGIST, 2021, 26 (12) : 1079 - 1084
  • [9] Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma
    Wendlinger, Simone
    Wohlfarth, Jonas
    Kreft, Sophia
    Siedel, Claudia
    Kilian, Teresa
    Dischinger, Ulrich
    Heppt, Markus V.
    Wistuba-Hamprecht, Kilian
    Meier, Friedegund
    Goebeler, Matthias
    Schadendorf, Dirk
    Gesierich, Anja
    Kosnopfel, Corinna
    Schilling, Bastian
    CANCERS, 2022, 14 (09)
  • [10] Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials
    Pelster, Meredith S.
    Amaria, Rodabe N.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
12345